Results 51 to 60 of about 580,991 (316)

Neutropenic colitis

open access: yesJournal of the Belgian Society of Radiology, 2011
Background: A 66-year-old-woman, undergoing chemotherapy for recently diagnosed acute myeloid leukemia developed increasing abdominal pain over a period of several days. Laboratory results showed, apart from severe neutropenia, increasing infection parameters.
Talebian, A.   +6 more
openaire   +6 more sources

Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation

open access: yesMicrobiology spectrum, 2021
The gut microbiota and host immune response interaction influences the progression of intestinal inflammatory disease. As a well-recognized next-generation probiotic, Akkermansia muciniphila has been proved to play a crucial role in the progression of ...
Siwen Qu   +8 more
semanticscholar   +1 more source

Serum antibodies in first-degree relatives of patients with IBD: A marker of disease susceptibility? A follow-up pilot-study after 7 years [PDF]

open access: yes, 2005
Introduction: Various disease-specific serum antibodies were described in patients with inflammatory bowel disease and their yet healthy first-degree relatives.
Bansi DS   +29 more
core   +5 more sources

Patch-level instance-group discrimination with pretext-invariant learning for colitis scoring [PDF]

open access: yesarXiv, 2022
Inflammatory bowel disease (IBD), in particular ulcerative colitis (UC), is graded by endoscopists and this assessment is the basis for risk stratification and therapy monitoring. Presently, endoscopic characterisation is largely operator dependant leading to sometimes undesirable clinical outcomes for patients with IBD. We focus on the Mayo Endoscopic
arxiv  

Bcl-3 deficiency protects against dextran-sodium sulphate-induced colitis in the mouse [PDF]

open access: yes, 2013
Bcl-3 is a member of the IκB family of proteins and is an essential negative regulator of Toll-like receptor induced responses. Recently, a single nucleotide polymorphism associated with reduced Bcl-3 gene expression has been identified as a potential ...
Araki   +26 more
core   +1 more source

SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study

open access: yesAnnals of Medicine
Introduction Vaccination hesitancy is an important barrier to vaccination among IBD patients. The development of adverse events is the main concern reported.
Laura N. Rossier   +6 more
doaj   +1 more source

Codesign and implementation of an equity-promoting national health literacy programme for people living with inflammatory bowel disease (IBD): a protocol for the application of the Optimising Health Literacy and Access (Ophelia) process

open access: yesBMJ Open, 2021
Introduction Non-government organisations (NGOs) often represent people who are underserved or experiencing vulnerability. Crohn’s & Colitis Australia (CCA) is aware that many Australians with inflammatory bowel disease (IBD) are not reached by ...
Melanie Hawkins   +8 more
doaj   +1 more source

Unsupervised physics-informed neural network in reaction-diffusion biology models (Ulcerative colitis and Crohn's disease cases) A preliminary study [PDF]

open access: yesarXiv, 2023
We propose to explore the potential of physics-informed neural networks (PINNs) in solving a class of partial differential equations (PDEs) used to model the propagation of chronic inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. An unsupervised approach was privileged during the deep neural network training.
arxiv  

An Etiologic Profile of Anemia in 405 Geriatric Patients

open access: yesAnemia, 2014
Background. Anemia is a common condition in the elderly and a significant risk factor for increased morbidity and mortality, reducing not only functional capacity and mobility but also quality of life.
Tabea Geisel   +6 more
doaj   +1 more source

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

open access: yesNew England Journal of Medicine, 2017
BACKGROUND Tofacitinib, an oral, small‐molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial.
W. Sandborn   +17 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy